IRCT2016080614882N4已完成未知
Evaluation of sylimarin effect on non alcoholic fatty liver on children and adolescents
Vice Chancellor for Research of Shahrekord University of Medical Science0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 16 years（—）
- 性别
- All
入选标准
- •Inclusion criteria : Obese or overweight child and adolescent with sonographic finding of
- •fatty liver
- •Exclusion criteria: Age less than 5 and more than 16 years old; patients with metabolic syndromes; viral hepatitis; wilson disease; auto immune hepatitis; juvenile hemochromatosis and other underlying diseases; allergy or intolerance to medication
排除标准
- 未提供
研究者
相似试验
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
招募中
2 期
Comparison the effects of silymarin and N-acetylcysteine on improvement of, Hepatic and renal Abnormalities in Patients with SeverePreeclampsia in post-partumPreeclampcia.Severe pre-eclampsiaO14.1IRCT20191231045965N1Shahre-kord University of Medical Sciences60
尚未招募
3 期
Effect of silymarin in the treatment of patients with depressioIRCT20160804029191N4Mashhad University of Medical Sciences80
招募中
3 期
Evaluating the effect of silymarin oral form on the control of liver toxicity caused by adriamycin and cyclophosphamide drugs in patients with non metastatic breast cancerIRCT2017091136125N1Vice chancellor for research, Mashhad University of Medical Sciences40
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140